ArisGlobal launches new version of medical information management system

Read more

Stem cells in predictive toxicology

Read more

New second-line drug for type II diabetes results in less hypoglycaemia: The Lancet

Read more

Imminent patent expiry of key blockbusterdDrugs to benefit generics manufacturers: Frost & Sullivan

Read more

Mylan confirms first-to-file patent challenge relating to Pristique tablets

Read more

Drug pricing norms: Cost or MRP based?

Read more

Venus Remedies: Reinventing R&D

Read more

Regulatory woes of pharma SMEs (Part I)

Read more

Back to the roots —Landscaping OTC opportunities in the Indian ayurveda market

Read more

A holistic view of the HPAPI opportunity

Read more